scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.74
3.04%
After-hours: Aug 15, 2025, 07:07 PM EDT

scPharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-91.72M -90.78M -85.15M -80.11M -60.64M -57.71M -54.81M -50.25M -44.77M -40.32M -36.84M -34.91M -31.3M -28.66M -28.03M -28.5M -30.99M -32.22M
Depreciation & Amortization
44K 32K 20K 156K 515K 572K 626K 606K 452K 471K 468K 459K 453K 434K 438K 431K 420K 410K
Stock-Based Compensation
5.33M 5.3M 5.44M 5.57M 5.63M 5.32M 4.86M 4.18M 3.68M 3.18M 2.84M 2.74M 2.57M 2.48M 2.37M 1.86M 1.98M 2.01M
Other Working Capital
-3.38M -4.19M -4.55M -5.16M -730K 904K 5.56M 4.51M 4.1M 4M -887K -371K 432K 72K -234K -494K 638K 837K
Other Non-Cash Items
27.36M 26.31M 22.24M 19.21M -1.08M -2.34M -770K -912K -1.4M -1.84M -695K 417K 489K 470K 558K 669K 656K 724K
Deferred Income Tax
n/a n/a n/a -1.56M -2.23M -2.83M -2.83M -1.26M -597K n/a n/a n/a 5K 120K 120K 75K 116K n/a
Change in Working Capital
-6.87M -10.84M -13.09M -13.77M -8.72M -3.46M -6.32M -8.29M -8.03M -5.19M -350K 1.46M 970K -747K -2.6M -3.76M -1.06M 507K
Operating Cash Flow
-65.86M -69.98M -70.54M -70.51M -66.54M -60.45M -59.24M -55.92M -50.67M -43.7M -34.58M -29.84M -26.81M -25.91M -27.15M -29.23M -28.87M -28.57M
Capital Expenditures
-21K -21K -21K -46K -37K -40K -40K -9K -24K -21K -27K -30K -25K -25K -19K -10K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a -9.43M -9.43M -9.43M -20.23M -10.8M -10.8M -10.8M n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -38.92M -50.59M -50.59M -97.49M -58.56M -54.75M -67.54M -20.65M -21.66M -17.8M -9.01M -11.01M -39.68M -35.69M
Sales Maturities Of Investments
n/a 1K 29.32M 55.82M 71.82M 92.92M 70.6M 48M 42.8M 28.7M 21.7M 22.3M 22.05M 24.45M 41.15M 75.35M 64.8M 55.4M
Other Investing Acitivies
n/a n/a n/a n/a n/a 9.43M 16.43M 16.44M 27.23M 16.94M -2.84M -2.84M -13.64M -7.38M 18.11M 54.8M 25.12M -20.75M
Investing Cash Flow
-21K -20K 29.3M 55.77M 32.86M 42.28M 19.96M -49.49M -15.78M -26.07M -45.86M 1.63M 371K 6.63M 32.13M 64.33M 25.12M -20.75M
Debt Repayment
-5.2M -5.2M -4.23M -4.23M n/a n/a n/a 37.3M 34.8M 32.3M 29.8M -7.5M -5M -2.5M n/a n/a n/a n/a
Common Stock Repurchased
-5.54B 166K n/a n/a 10.27B 4.72B 4.72B 4.72B n/a n/a n/a 81K 81K 81K n/a -81K -161K -161K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
73.39M 74.01M 73.84M 20.58M -443K -166K n/a -120K -165K -358K -337K -2.37M -2.4M -2.48M -2.49M 28K 28K -211K
Financial Cash Flow
68.19M 69.09M 70.08M 71.18M 833K 1.16M 14.85M 98.98M 96.44M 93.41M 77.23M -9.83M -7.35M -4.94M -2.53M -52K -134K 49.82M
Net Cash Flow
2.31M -903K 28.84M 56.44M -32.85M -17.01M -24.43M -6.43M 29.99M 23.64M -3.21M -38.03M -33.79M -24.21M 2.45M 35.05M -3.89M 498K
Free Cash Flow
-65.88M -70M -70.56M -70.56M -66.57M -60.49M -59.28M -55.93M -50.69M -43.72M -34.6M -29.87M -26.83M -25.93M -27.17M -29.24M -28.87M -28.57M